Spyre Therapeutics Stock (NASDAQ: SYRE) stock price, news, charts, stock research, profile.
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Other companies in Spyre Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Syndax Pharmaceuticals (NASDAQ:SNDX), Day One Biopharmaceutical (NASDAQ:DAWN), CareDx (NASDAQ:CDNA) and Xencor (NASDAQ:XNCR).
Spyre Therapeutics has a consensus price target of $48.00.
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $23.59 last updated December 23, 2024 at 4:00 PM EST.
There are no upcoming dividends for Spyre Therapeutics.
Spyre Therapeutics’s Q4 earnings are confirmed for Thursday, February 27, 2025.
There is no upcoming split for Spyre Therapeutics.
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.